Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Sugammadex for Reversal of Rocuronium-induced Neuromuscular Block on Perioperative Management of Awake Craniotomy

NCT05202899 is registered in ClinicalTrials.gov with Guangzhou General Hospital of Guangzhou Military Command as lead sponsor.

NCT NCT05202899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05202899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Sugammadex for Reversal of Rocuronium-induced Neuromuscular Block on Perioperative Management of Awake Craniotomy
Lead sponsor
Guangzhou General Hospital of Guangzhou Military Command
Phase
Phase 4
Overall status
Unknown status
Start date
September 1, 2020
Completion date
May 31, 2022
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumors